CLDX : Summary for Celldex Therapeutics, Inc. - Yahoo Finance

U.S. Markets open in 8 hrs 59 mins

Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.27+0.03 (+0.93%)
At close: 4:00PM EDT
People also watch
ACADARRYCLVSSRPTSGEN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close3.24
Open3.24
Bid3.27 x 1000
Ask4.19 x 2000
Day's Range3.17 - 3.36
52 Week Range2.85 - 5.13
Volume1,429,177
Avg. Volume1,926,651
Market Cap402.91M
Beta3.03
PE Ratio (TTM)-2.58
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
    Capital Cube3 days ago

    Celldex Therapeutics, Inc. :CLDX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017

    Categories: Yahoo Finance Get free summary analysis Celldex Therapeutics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Celldex Therapeutics, Inc. – Seattle Genetics, Inc., Emergent BioSolutions Inc., Agenus Inc., GlaxoSmithKline plc Sponsored ADR, Amgen Inc., Vical Incorporated, Bristol-Myers Squibb Company, Pfizer Inc. and CytRx Corporation ... Read more (Read more...)

  • Celldex Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CLDX-US : March 17, 2017
    Capital Cube7 days ago

    Celldex Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : CLDX-US : March 17, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Celldex Therapeutics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat
    Zacks9 days ago

    Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat

    Celldex Therapeutics, Inc. (CLDX) posted fourth-quarter 2016 loss of 30 cents per share, narrower than both the Zacks Consensus Estimate of a loss of 34 cents and the year-ago loss of 33 cents.